after bombing, however, some terrorists may survive, as do those cancer
cells that are resistant to the usual therapies. Rather than bombing the
city again, however, Dr. Ghoneurn advocates sending in special forces to
locate and eliminate the remaining terrorists one by one.
Dr. Ghoneum's development of a natural supplement
called MGN-3 is meant to arm the body's Natural Killer cells to seek and
destroy dangerous invaders.
The human immune system is comprised of more than
130 subsets of white blood cells. About 15% of them are called Natural
Killer (NK) cells. These provide the first line of defense for dealing
with any form of invasion to the body. Each cell contains several small
granules which act as 'ammunition.' When an NK cell recognizes a cancer
cell, for instance, it attaches itself to the cell's outer membrane and
injects these granules directly into the interior of the cell.
The granules then 'explode,' destroying the cancer
cell within five minutes. The killer cell then moves on to other cancer
cells and repeats the process. As long as NK cells remain active, the body
is able to keep disease under control.
The supplement developed by Dr. Ghoneum, called MGN-3,
increases the efficacy of the NK cells. Additionally, it has other immune-boosting
effects as well: it increases levels of interferon, a compound produced
by the body that inhibits the replication of viruses; it increases the
formation of Tumor Necrosis Factors, a group of proteins that help destroy
cancer cells, and it increases the activity of T-cells and B-cells. This
potent immune system booster is made of the outer shell of rice bran which
has been enzymatically treat- ed with extracts from three different medicinal
mushrooms: Shiitake, Kawaratake and Suehirotake. In Japan, these mushroom
extracts have become the leading prescription treatments for cancer.
Dr. Ghoneum's findings have been demonstrated in
test-tube experiments as well as seven published studies involving 72 patients.
In a study presented to the American Association for Cancer Research, he
reported on five patients with breast cancer. Each patient was treated
with the same dosage of three grams a day of MGN- 3 from a Japanese manufacturer.
NK cell activity increased within two weeks and continued to do so as the
study progressed. At the end of the six- to eight-month study, two of the
patients were in complete re-mission. In a study reported the following
year, 27 patients with various types of cancers including breast, cervical,
prostate, leukemia and multiple myeloma were test- ed for NK cell activity
by 51 Chromium- release assay [see Quick Definition] before and after only
two weeks treatment with MGN-3.
NK cell activity increased 154-332% for breast carcinoma,
100-275% in cervical cancer; 174-385% in prostatic cancer; 100-240%
in leukemia and 100- 537% in multiple myeloma.
One multiple myeloma patient was a 58-year-old man
diagnosed in 1990. He under- went several months of chemotherapy following
his diagnosis. Although his condition seemed to stabilize, his blood still
showed markers for multiple myeloma eight months after chemotherapy.
He then began taking MGN-3 and in less than 6 months,
follow-up lab work showed no indication of cancer. Today eight years after
his initial diagnosis, he is the first patient known to have survived multiple
myeloma, according to Dr. Ghoneum.
Dr. Warren Levin, 66, a holistic physician practicing
in New York City and Ridgefield, Connecticut, had suffered from an immune
deficiency with an abnormal ratio of helper cells to suppressor cells since
the early '80s. "I tried herbs, healers, intravenous treatments-all sorts
of stuff. Several years ago, I learned about glyconutrients - carbohydrate
molecules that play a critically important role in cell-to-cell communication.
I began looking for glyconutrient sources. All over the world, native populations
were using substances with high glyconutrient content including Aloe Vera,
astralagus, echinacea and various mushrooms.
At that point, I read an article about MGN-3. I was
already taking Coats Aloe Vera Concentrate together with Beta 1-3, D- glucan
(Macroforce), Ambrotose, and a thymus preparation called Basic Thymic Protein
A as well as the usual vitamins, minerals and antioxidants. I also did
intensive mercury detoxification with DMPS. Last fall, I began taking six
capsules a day of MGN-3. At the end of December, I sent my blood to the
laboratory and when I returned from vacation I found that for the first
time in 15 years, every one of my tests had improved well into the middle
range of normalcy. That combination of supplements had finally reversed
my helper-cell ratio. And normalized my mitogen/allergen responses and
NK cell activity."
Dr. Ghoneum's latest study, reported in the
International Journal of lmmunotherapy, involved 24 patients. Doctors tested
NK cell activity in each patient, administered the recommended cancer dosage
of 3 grams per day, and tested NK cell activity again after 16 hours, one
week, one month and two months. After 16 hours NK cell activity had increased
1.3 to 1.5 times. After one week, activity had increased eightfold. At
the end of two months, NK cells were killing 27 times more cancer cells
than prior to taking MGN-3.
Unlike other forms of cancer treatment, MGN-3 is
a totally harmless substance and has no known side effects. In the terrorist
analogy, it doesn't kill innocent civilians. David A. Pitts, 73, a real
estate salesman in Santa Barbara, California, had under- gone chemotherapy
for lymphoma with no apparent results. "I had been getting weaker and weaker,"
he said. After a report on MGN-3, he sent for the supplement and began
taking it while he was also placed on a course of intravenous treatment
with trioxine, a relatively new drug. "In about three to four weeks on
the outside, gosh, I started feeling better," says Pitts. "What really
intrigued me was the idea that this supplement could enhance your immune
system. When I began, I did a crash pro- gram of 14 capsules a day. Now
I'm on a preventative program of four a day." At his latest CAT-scan, Pitts
was in remission. "The doctor had no explanation of how or why this happened,
and there's nothing I can prove. But I'm going to continue taking this
for the rest of my life. What's in it is harmless and doesn't interfere
with any- thing else."
Dr. Ghoneum has also used MGN-3 to treat
hepatitis B and C and has done in vitro experiments demonstrating its action
against HIV. He believes that individuals in "high risk" categories for
disease can benefit from using MGN-3 preventively. These include:
• Heavy smoker
• Heavy drinkers
• Individuals, such as artists and house painters,
who constantly work with paint
• Those born with immune deficiencies
• Families with a strong history of cancer
• Chemical and refinery workers
to MGN-3 index